Home  >  Products  >  SECISBP2 (SECIS binding protein 2 ) Blocking Peptide (the N terminal of SECISBP2)(100ug)
SECISBP2 (SECIS binding protein 2 ) Blocking Peptide (the N terminal of SECISBP2)(100ug)

SECISBP2 (SECIS binding protein 2 ) Blocking Peptide (the N terminal of SECISBP2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SECISBP2 Antibody (ARP41002_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP41002
Size: 100ug
Weight: 95kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: The incorporation of selenocysteine into a protein requires the concerted action of an mRNA element called a sec insertion sequence (SECIS), a selenocysteine-specific translation elongation factor and a SECIS binding protein. With these elements in place, a UGA codon can be decoded as selenocysteine. The gene described in this record encodes a nuclear protein that functions as a SECIS binding protein. Mutations in this gene have been associated with a reduction in activity of a specific thyroxine deiodinase, a selenocysteine-containing enzyme, and abnormal thyroid hormone metabolism.
Alternative names: DKFZp686C09169; SBP2
See Full Product Listings >